Perrigo (PRGO) Stock Price, News & Analysis

Company Overview

Perrigo Company plc (NYSE: PRGO) is a global consumer self-care company that develops, manufactures and sells over-the-counter (OTC) health and wellness products. Its portfolio includes products for pain relief, allergy and cold relief, digestive health, sleep support, skin care, women’s health and oral care. Perrigo supplies both its own brands and retailer-owned store brands.

The company markets products under a range of brand names, including Compeed, ACO, ellaOne and other regional brands, while also producing private-label alternatives to widely used consumer health products. Perrigo sells through pharmacies, supermarkets, mass retailers, e-commerce channels and other healthcare outlets.

Founded in 1887 in Allegan, Michigan, Perrigo has expanded from a U.S. supplier of private-label medicines into an international consumer health company. It serves customers across North America, Europe and other global markets, with operations and products tailored to regional consumer and regulatory requirements. Patrick Lockwood-Taylor has served as Perrigo’s president and chief executive officer since 2023.

Key Stats

• Today's Range: $14.02 to $14.50
• 50-Day Range: $10.09 to $15.43
• 52-Week Range: $9.23 to $22.48
• Volume: 595,521 shs
• Average Volume: 3.09 million shs
• Market Capitalization: $2.01 billion
• P/E Ratio: N/A
• Dividend Yield: 8.01%
• Price Target: $19.33
• Consensus Rating: Hold

Perrigo Stock Analysis - MarketRank™

Perrigo scored higher than 60% of companies evaluated by MarketBeat, and ranked 238th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

Perrigo has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 4 hold ratings, and 1 sell rating.

Upside Potential

Perrigo has a consensus price target of $19.33, representing about 36.1% upside from its current price of $14.21.

Amount of Analyst Coverage

Perrigo has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 8.26%

Earnings Growth

Earnings for Perrigo are expected to grow by 8.26% in the coming year, from $2.18 to $2.36 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Perrigo is -1.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Perrigo is -1.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Perrigo has a PEG Ratio of 1.63. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Perrigo has a P/B Ratio of 0.67. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

16.38% of the float of Perrigo has been sold short.

Short Interest Ratio / Days to Cover

Perrigo has a short interest ratio ("days to cover") of 9.34.

Change versus previous month

Short interest in Perrigo has recently increased by 0.35%, indicating that investor sentiment is decreasing.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Leadership

Perrigo is a leading dividend payer. It pays a dividend yield of 8.13%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Perrigo has been increasing its dividend for 23 years.

Dividend Sustainability

Based on earnings estimates, Perrigo will have a dividend payout ratio of 49.15% next year. This indicates that Perrigo will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

Search Interest

Only 11 people have searched for PRGO on MarketBeat in the last 30 days. This is a decrease of -61% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Perrigo insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.40% of the stock of Perrigo is held by insiders.

Percentage Held by Institutions

95.91% of the stock of Perrigo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/05/2026
• Record date for 9/15 Dividend: 8/28/2026
• Ex-Dividend for 9/15 Dividend: 8/28/2026
• Dividend Payable: 9/15/2026
• Today: 10/05/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NYSE:PRGO
• CIK: 1585364
• Web: www.perrigo.com
• Phone: (531) 709-4000
• Fax: 269-673-9128
• Employees: 8,100
• Year Founded: 1887

Price Target and Rating

• Average Price Target for Perrigo: $19.33
• High Price Target: $23.00
• Low Price Target: $17.00
• Potential Upside/Downside: +34.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): ($12.51)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 6.62
• P/E Growth: 1.63
• Net Income: -$1.43 billion
• Net Margins: -41.85%
• Pretax Margin: -38.90%
• Return on Equity: 11.25%
• Return on Assets: 4.08%

Debt

• Debt-to-Equity Ratio: 1.31
• Current Ratio: 2.32
• Quick Ratio: 1.32

Sales & Book Value

• Annual Sales: $4.25 billion
• Price / Sales: 0.47
• Cash Flow: $5.34 per share
• Price / Cash Flow: 2.70
• Book Value: $21.33 per share
• Price / Book: 0.68

Miscellaneous

• Outstanding Shares: 138,770,000
• Free Float: 138,214,000
• Market Cap: $2.00 billion
• Optionable: Optionable
• Beta: 0.69